Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP

Outcome
Finished, no results posted
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
1 December 2020
Ended
31 December 2023
Enrollment
269 participants
Sites
6
Primary outcomes
Rate of patients who have germline genetic tests
Sponsor type
Academic / other
Results posted
No
Last update
19 January 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.

Detailed description public domain (ClinicalTrials.gov)

This prospective, randomized controlled trial will evaluate the effect of two pre-test education methods on the level of participation in genetic testing for hereditary cancer risk. A prospective study examines outcomes before the development of a disease. * The research study procedures include screening for eligibility, randomization and a series of questionnaires. * Participants will be randomized, or assigned by chance, to one of two methods of pre-genetic test education and after completing either pre-test education participants will be offered the opportunity to have genetic testing performed Two methods of pre-genetic test education: * video education * in-person counseling * Genetic testing will be performed by blood draw. * It is expected that 500 people will participate in this study * Participants will be in the research study for up to 5 yrs after enrollment